Authored By: Sarah
24 Jan 2025

Bioinformatics Market Growth Forecast: Advancements in Genomics and Precision Medicine Drive Expansion (2024-2028)

The bioinformatics market is experiencing robust growth, with a projected increase of USD 13.2 billion, driven by a compound annual growth rate (CAGR) of 16.59% from 2023 to 2028. This surge is largely attributed to technological advancements in genetic sequencing, the growing adoption of next-generation sequencing (NGS) tools, and the rising demand for personalized healthcare solutions. Bioinformatics plays a critical role in genomics data analysis, and as NGS technologies evolve, they facilitate more precise and cost-effective approaches to disease diagnosis and therapeutic development.

Global bioinformatics market 2024-2028

For more details about the industry, get the PDF sample report for free

Key Drivers of Market Growth

Reduction in Genetic Sequencing Costs: The cost of genome sequencing has dramatically decreased, primarily due to the success of the Human Genome Project and the subsequent development of advanced technologies such as NGS. These innovations have paved the way for the widespread use of genomic sequencing in clinical settings, fueling growth in the bioinformatics market. NGS platforms, coupled with DNA microarrays and CRISPR technologies, now offer affordable and high-throughput solutions for genomic analysis, making personalized medicine a more viable option.

Advancements in NGS and Bioinformatics Tools: NGS technology has revolutionized genomic research and drug discovery. As bioinformatics tools become more sophisticated, they are enabling researchers to handle complex datasets generated by these technologies. Bioinformatics solutions are crucial for interpreting vast amounts of genomic data, especially in areas like gene therapy, drug development, and disease biomarker identification. As the market evolves, tools for the analysis of molecular phylogenetics, transcriptomics, and proteomics continue to gain prominence, driving further market expansion.

Growing Demand for Personalized Medicine: Precision medicine, which tailors treatment based on individual genetic makeup, is one of the fastest-growing application areas in bioinformatics. The development of personalized healthcare solutions is accelerating as bioinformatics tools help identify genetic markers and predict treatment responses. This shift toward personalized medicine is enabling more targeted therapies, thereby improving patient outcomes and reducing healthcare costs.

Market Segmentation: Applications and Products

The bioinformatics market can be segmented based on applications, products, and services.

Applications:

  1. Molecular Phylogenetics: This segment is expected to witness significant growth during the forecast period. Molecular phylogenetics is used to analyze evolutionary relationships among species through molecular data, including DNA and RNA sequences. This technique is particularly important in fields like viral research, where it helps trace the origin and spread of pathogens.

  2. Transcriptomics: This area focuses on RNA studies and is critical in the analysis of gene expression and regulation. It is essential for drug discovery and the development of RNA-based therapeutics.

  3. Proteomics and Metabolomics: Proteomics, the study of proteins, and metabolomics, the analysis of metabolic profiles, are growing fields within bioinformatics. These segments support the identification of biomarkers and therapeutic targets.

Products:

  1. Platforms: Bioinformatics platforms facilitate the integration and analysis of genomic data. These platforms are increasingly cloud-based, allowing for real-time collaboration across research teams and reducing the time required to analyze genomic data.

  2. Tools: Advanced bioinformatics tools are used for analyzing complex datasets generated through NGS, DNA sequencing, and other molecular biology techniques. These tools play an essential role in enabling researchers to interpret genomic data accurately.

  3. Services: Bioinformatics service providers offer data analysis, genome sequencing, and other bioinformatics solutions to academic, research, and healthcare institutions. These services are crucial for efficient data interpretation and therapeutic development.

Geography:

  1. North America
    • Canada
    • US
  2. Europe
    • Germany
    • UK
    • France
  3. Asia
  4. Rest of World (ROW)

Regional Market Trends

The bioinformatics market's growth is not limited to a single region; it is expanding across various global markets. Here’s a breakdown of regional insights:

North America:

  • Countries: US, Canada
  • Market Share: North America is expected to contribute significantly to the global bioinformatics market, with an estimated 44% market share by 2028. The demand for bioinformatics solutions in North America is driven by the presence of top research institutions, pharmaceutical companies, and well-established healthcare systems. Chronic diseases such as cancer, diabetes, and cardiovascular diseases contribute to the growing need for advanced bioinformatics tools to assist in drug discovery and personalized treatments.

Europe:

  • Countries: Germany, UK, France
  • Europe's bioinformatics market is growing steadily, fueled by investments in research and development, particularly in genomics and transcriptomics. As personalized medicine gains momentum, European companies are leveraging bioinformatics solutions for drug development and clinical diagnostics.

Asia-Pacific:

  • The Asia-Pacific region is emerging as a key player in the bioinformatics market. The growth in this region is largely driven by increased research activities, particularly in China and India, as well as rising healthcare investments. Governments are focusing on improving healthcare infrastructure, which bodes well for the adoption of bioinformatics solutions in both research and clinical settings.

Rest of the World (ROW):

  • In regions outside the major markets, the bioinformatics industry is witnessing gradual growth, especially in regions with expanding healthcare and research sectors. The focus is on providing bioinformatics tools and solutions to emerging markets to facilitate advancements in genomics and healthcare.

Challenges and Market Outlook

Despite its rapid growth, the bioinformatics market faces some challenges. The shortage of trained laboratory professionals remains a significant barrier. The complexity of genomic data analysis requires skilled personnel, and there is an ongoing demand for education and training to address this gap.

However, the increasing use of artificial intelligence (AI) and cloud-based bioinformatics solutions is helping mitigate this challenge. AI-driven data analysis platforms are enhancing the efficiency of bioinformatics research, and cloud platforms are making data sharing and collaboration easier for research teams globally.

Get more details by ordering the complete report

Key Market Players

Leading companies in the bioinformatics market are continuously innovating to meet the growing demand for bioinformatics solutions. Some of the prominent players in the market include:

  • Agilent Technologies Inc.
  • Azenta Inc.
  • Bio Rad Laboratories Inc.
  • Biomax Informatics AG
  • DNASTAR Inc.
  • Eurofins Scientific SE
  • Fios Genomics Ltd.
  • Genedata AG
  • Geneva Bioinformatics SA
  • Illumina Inc.
  • Partek Inc.
  • Perkin Elmer Inc.
  • Precigen Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Seven Bridges Genomics Inc.
  • Source BioScience
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
  • ZS Associates Inc.

Latest Developments

Several recent developments underscore the dynamism in the bioinformatics sector:

  • December 2024: Thermo Fisher Scientific launched a new bioinformatics platform in December 2024 that integrates AI-driven data analysis tools for more efficient genomic research.
  • November 2024: Illumina expanded its bioinformatics software suite in November 2024 to include advanced data visualization tools, enhancing the research community's ability to interpret genetic sequences.
  • October 2024: QIAGEN formed a strategic partnership in October 2024 to integrate bioinformatics solutions into pharmaceutical drug development processes, improving clinical trial data interpretation.

As the bioinformatics field continues to evolve, these advancements in tools, technologies, and collaborative efforts promise to drive further innovation in the healthcare and research sectors.

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.